A Retrospective Study of Characteristics of Early Adopters of Budesonide/Glycopyrrolate/Formoterol in Patients with Copd
Latest Information Update: 30 Nov 2022
At a glance
- Drugs Budesonide/formoterol/glycopyrrolate (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
Most Recent Events
- 30 Nov 2022 New trial record
- 19 Oct 2022 Results presented at the CHEST Annual Meeting 2022 by Annual Meeting of the American College of Chest Physicians